journal article·2023-06-12

Bilayer Silk Fibroin/Sodium Alginate Scaffold Delivered hUC-MSCs to Enhance Skin Scarless Healing and Hair Follicle Regeneration with the IRE1/XBP1 Pathway Inhibition

Zhaona Dou, Tong Qiu, Yimeng Ren, Xinyu Wang, Quan Wen, Ying Shen, Lin Wu, Lei Han, Tao Jiang, Xinke Xia

Publisher page

Abstract

Efficient local delivery of mesenchymal stem cells (MSCs) is a decisive factor for their application in regeneration processes. Here, we prepared a biomimetic bilayer silk fibroin/sodium alginate (SF/SA) scaffold to deliver human umbilical mesenchymal stem cells (hUC-MSCs) for wound healing. An SA membrane was prepared by the casting method on the upper layer of the scaffold to simulate the dense epidermal structure. On the lower layer, porous materials simulating the loose structure of the dermis were formed by the freeze-drying method. In vitro, the scaffold was proven to have a high-density pore structure, good swelling property, and suitable degradation rate. The hUC-MSCs could survive on the scaffold for up to 14 days and maintain cell stemness for at least 7 days. In vivo, SF/SA scaffolds loaded with hUC-MSCs (M-SF/SA) were applied to full-thickness defect wounds and compared with the local injection of hUC-MSCs. The M-SF/SA group showed excellent therapeutic efficacy, characterized by induction of macrophage polarization, regulation of TGF-β expression and collagen components, and enhancement of vascular regeneration, thereby preventing scar formation and promoting hair follicle regeneration. Furthermore, the expression of endoplasmic reticulum stress markers IRE1, XBP1, and CHOP was inhibited significantly in M-SF/SA treatment. In conclusion, the bilayer SF/SA scaffold is an ideal delivery platform for hUC-MSCs, and the M-SF/SA system could locally promote scarless skin healing and hair follicle regeneration by alleviating the IRE1/XBP1 signal pathway.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Wound Healing and Treatments · Hair Growth and Disorders · Nerve injury and regeneration

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Advanced Technology for Materials Synthesis and Processing, Biomedical Materials and Engineering Research Center of Hubei Province, Wuhan University of Technology, Wuhan, Hubei 430070, China

School of Chemistry, Chemical Engineering and Life Sciences, Wuhan University of Technology, Wuhan, Hubei 430070, China

Yinfeng Academy of Life Science, Yichang Laboratory of Hematopoietic Stem Cells, 1109 Gangxing Sanlu, Jinan, Shandong Province 250100, China

Institute of Life Science, Yinfeng Biological Group, High-tech Zone, Jinan, Shandong Province 250100, China

Funding

Foundation for Innovative Research Groups of Hubei Province of China · Technology Boosts Economy 2020 · Institute of Life Science of Yinfeng Biological Group

References (49)

Show source-provided references
1. 10.4252/wjsc.v12.i7.65910.4252/wjsc.v12.i7.659 ↗
2. 10.1016/j.biopha.2018.02.09310.1016/j.biopha.2018.02.093 ↗
3. 10.1080/14712598.2019.159625710.1080/14712598.2019.1596257 ↗
4. 10.1016/j.reactfunctpolym.2022.10523310.1016/j.reactfunctpolym.2022.105233 ↗
5. 10.1039/C9TB02418B10.1039/C9TB02418B ↗
6. 10.1016/j.colsurfb.2020.11136110.1016/j.colsurfb.2020.111361 ↗
7. 10.1002/app.2071410.1002/app.20714 ↗
8. 10.1016/j.eurpolymj.2021.11026710.1016/j.eurpolymj.2021.110267 ↗
9. 10.3389/fbioe.2022.84158310.3389/fbioe.2022.841583 ↗
10. 10.1111/iwj.1352510.1111/iwj.13525 ↗
11. 10.1016/j.ijbiomac.2019.08.00710.1016/j.ijbiomac.2019.08.007 ↗
12. 10.1371/journal.pone.012357810.1371/journal.pone.0123578 ↗
13. 10.1093/ibd/izaa01510.1093/ibd/izaa015 ↗
14. 10.1155/2018/175792510.1155/2018/1757925 ↗
15. 10.1155/2020/858631410.1155/2020/8586314 ↗
16. 10.1111/wrr.1260310.1111/wrr.12603 ↗
17. 10.1152/ajpendo.00155.202010.1152/ajpendo.00155.2020 ↗
18. 10.1016/j.rvsc.2021.02.00110.1016/j.rvsc.2021.02.001 ↗
19. 10.3390/ijms2209493010.3390/ijms22094930 ↗
20. 10.1039/C8BM00934A10.1039/C8BM00934A ↗
21. 10.1016/j.compositesb.2021.10916510.1016/j.compositesb.2021.109165 ↗
22. 10.1016/j.colsurfb.2019.11073510.1016/j.colsurfb.2019.110735 ↗
23. 10.3390/molecules2620611010.3390/molecules26206110 ↗
24. 10.1002/mabi.20210035210.1002/mabi.202100352 ↗
25. 10.1038/srep3947710.1038/srep39477 ↗
26. 10.1088/1758-5090/ac73b710.1088/1758-5090/ac73b7 ↗
27. 10.1002/mabi.20200038410.1002/mabi.202000384 ↗
28. 10.1038/s41368-022-00198-w10.1038/s41368-022-00198-w ↗
29. 10.1089/ten.teb.2020.002110.1089/ten.teb.2020.0021 ↗
30. 10.1002/jbm.a.3614810.1002/jbm.a.36148 ↗
31. 10.1089/ten.teb.2018.035010.1089/ten.teb.2018.0350 ↗
32. 10.1021/acsnano.9b0180210.1021/acsnano.9b01802 ↗
33. 10.1016/j.addr.2018.07.01910.1016/j.addr.2018.07.019 ↗
34. 10.3390/ijms1807154510.3390/ijms18071545 ↗
35. 10.3389/fcell.2020.0069710.3389/fcell.2020.00697 ↗
36. 10.1111/jgh.1436210.1111/jgh.14362 ↗
37. 10.1002/jbm.a.3599910.1002/jbm.a.35999 ↗
38. 10.1155/2019/713270810.1155/2019/7132708 ↗
39. 10.3390/cells1007172910.3390/cells10071729 ↗
40. 10.1186/s13287-019-1457-910.1186/s13287-019-1457-9 ↗
41. 10.1016/j.msec.2015.07.06210.1016/j.msec.2015.07.062 ↗
42. 10.3390/ijms22191076510.3390/ijms221910765 ↗
43. 10.1016/j.apmt.2021.10106510.1016/j.apmt.2021.101065 ↗
44. 10.1016/j.bioactmat.2020.12.00610.1016/j.bioactmat.2020.12.006 ↗
45. 10.1039/C8NR09818B10.1039/C8NR09818B ↗
46. 10.1021/acs.jafc.8b0294910.1021/acs.jafc.8b02949 ↗
47. 10.1016/j.jep.2021.11463410.1016/j.jep.2021.114634 ↗
48. 10.1016/j.bioactmat.2020.09.00810.1016/j.bioactmat.2020.09.008 ↗
49. 10.1002/adhm.20207002910.1002/adhm.202070029 ↗